Conn Sugihara

The benefit of a remotely monitored implantable loop recorder as a first line investigation in unexplained syncope: the EaSyAS II trial

Neil Sulke, Conn Sugihara, Paul S.G. Hong et al. · EP Europace · 2015 · 85 citations · Full text

Are implantable cardiac monitors the ‘gold standard’ for atrial fibrillation detection? A prospective randomized trial comparing atrial fibrillation monitoring using implantable cardiac monitors and DDDRP permanent pacemakers in post atrial fibrillation ablation patients

Steven Podd, Conn Sugihara, Stephen Furniss et al. · EP Europace · 2015 · 57 citations

A double-blind, randomised, placebo-controlled, cross-over study assessing the use of XEN-D0103 in patients with paroxysmal atrial fibrillation and implanted pacemakers allowing continuous beat-to-beat monitoring of drug efficacy

S. R. Shunmugam, Conn Sugihara, Nick Freemantle et al. · Journal of Interventional Cardiac Electrophysiology · 2018 · 25 citations

Electrophysiological Evaluation, Device Therapy, Cardiovascular Disease +8

The effect of C-reactive protein reduction with a highly specific antisense oligonucleotide on atrial fibrillation assessed using beat-to-beat pacemaker Holter follow-up

Conn Sugihara, Nick Freemantle, Steven G. Hughes et al. · Journal of Interventional Cardiac Electrophysiology · 2015 · 11 citations

C-reactive Protein Reduction, Cardiovascular Disease, Specific Antisense Oligonucleotide +9

Lessons of the month 3: ST-elevation myocardial infarction and left ventricular thrombus formation: an arterial thrombotic complication of severe COVID-19 infection

Matthew J. Fenton, Seshnag Siddavaram, Conn Sugihara et al. · Clinical Medicine · 2020 · 11 citations · Full text